Previous studies on healthy elderly populations have reported either no significant progression of WMLs associated with age (36), or a mild increase of 0.2 to 0.4% per year (37), In this study, however, we observed significant deterioration of WMLs in patients with NSCLC who received EGFR-TKI therapy. Here, EGFR is linked to non-small cell lung carcinoma.